Topochemical analysis of morphiceptin and dermorphin bioactivities

Area of Science:

• Medicinal Chemistry
• Neuropharmacology
• Opioid Receptor Research

Background:

• Morphiceptin and dermorphin are known opioid peptides with distinct structures and activities.
• Understanding the structure-activity relationships of these peptides is crucial for developing new analgesics.
• Topochemical requirements for bioactivity at opioid receptors remain an area of active investigation.

Purpose of the Study:

• To elucidate the topochemical requirements for bioactivities of morphiceptin and dermorphin analogs.
• To investigate the role of chirality at residue 2 in determining opioid receptor interactions.
• To synthesize and characterize novel diastereomers of Tyr-(L and D)-(NMe)Ala-Phe-D-Pro-NH2.

Main Methods:

• Design and synthesis of two diastereomers: Tyr-(L)-(NMe)Ala-Phe-D-Pro-NH2 and Tyr-(D)-(NMe)Ala-Phe-D-Pro-NH2.
• Evaluation of biological activities using the guinea pig ileum assay.
• Computational studies on accessible space for the second residues to determine spatial configurations.

Main Results:

• Both synthesized analogs exhibited high mu-receptor activities in the guinea pig ileum assay.
• The L-(NMe)Ala2 analog adopted a cis configuration of the Tyr1-L-(NMe)Ala2 amide bond.
• The D-(NMe)Ala2 analog adopted a trans configuration of the Tyr1-D-(NMe)Ala2 amide bond.
• Accessible space analysis confirmed the L-analog's similarity to morphiceptin and the D-analog's to dermorphin.

Conclusions:

• High mu-receptor activities are linked to specific amide bond configurations (cis for L-analog, trans for D-analog).
• Chirality at residue 2 is a key determinant for classifying analogs within morphiceptin or dermorphin opioid families.
• The spatial array similarity suggests recognition at the same opioid receptor site, despite structural differences.